Global Intravenous System Access Devices Market - Future Scope Detailed Analysis to 2030

 Infinium Global Research recent report on the Intravenous System Access Devices Market (By Product Type (Implantable Port, Intravenous Catheter, Hypodermic Needles, Infusion Pumps, Others); By Application (Medication Administration, Fluid and Nutrient Administration, Blood Transfusion, Diagnostics), By End User (Hospitals, Clinics, Ambulatory Surgery Centers): Global Industry Analysis, Trends, Size, Share and Forecasts up to 2030 provides a comprehensive outline of the factors responsible for the growth of the market. The global intravenous system access devices market was valued at approximately USD 19 billion in 2022 and is expected to reach nearly USD 35 billion in 2030, with a CAGR of about 8% during the forecast period 2023-2030.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/11

"We are Now Including the Impact Analysis of COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2023-2030." 

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free.

A variety of medical devices are utilized for intravenous treatments, which involve administering medication or nutrition directly into a patient's bloodstream. Intravenous (IV) systems provide repeated and long-term access to the bloodstream for regular administration of drugs or nutrition. These systems typically involve the insertion of a catheter into a large vein in the arm or chest. Peripherally inserted central catheters (PICCs) are commonly used for intravenous access over a period of days, weeks, or months. The increasing preference for self-administration of drugs, especially among the elderly and individuals with chronic conditions, is also driving the demand for reusable electric auto-injectors. These devices offer patients greater independence and control over their treatment, which can improve their quality of life.

Medication Administration is the Fastest-Growing Segment in the Product Type of the Intravenous System Access Devices Market

Medication administration through intravenous system access devices involves the delivery of medications directly into a patient's bloodstream using a variety of medical devices, such as catheters, ports, and pumps. This method of medication delivery is often preferred over other routes, such as oral or topical, when rapid and precise drug delivery is required, or when oral or other routes are not feasible. Intravenous medication administration can be used for a wide range of drugs, including antibiotics, chemotherapy drugs, pain medication, and nutrition supplements. It is also commonly used for patients who require long-term medication therapy or for patients who are unable to swallow oral medication.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/11

North America Region Holds a Significant Share of the Intravenous System Access Devices Market

The North America region is projected to dominate the global Intravenous System Access Devices market, with the region expected to hold the largest share. One of the primary drivers is the rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, which require frequent and long-term intravenous therapy. Another factor contributing to the growth of intravenous system access devices is the increasing demand for home healthcare services, where patients can receive intravenous therapy in the comfort of their own homes. This is particularly important for patients who live in remote or rural areas, or who have difficulty traveling to hospitals or clinics.

Major Players Operating in the Intravenous System Access Devices Market are Focusing on Product Development

In July 2022, B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood. The report provides profiles of the companies in the global intravenous system access devices market such as Braun Melsungen AG, Becton, Dickinson and Company, Smiths Medical, Inc., Terumo Corporation, Teleflex Medical Inc., Edwards Lifesciences Corporation, Medical Components, Inc., ICU Medical Inc., Fresenius Medical Care Ag & Co KGaA, C.R.Bard, Inc. Infinium Global Research recent report on the Intravenous System Access Devices Market is an encompassment of such recent developments in the global marketplace. The report delivers insights into the recent developments by leading players that have contributed to the growth of the market and also estimates the impact of recent developments on the global market.

More Insights on This Report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/11

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of intravenous system access devices.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company. 

 => Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.